A new method for making γ-cyclodextrin could provide a cheaper and simpler route to this promising yet pricey host molecule. The synthesis, which uses a photoswitchable hydrazone template, might also ...
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc, (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results